"UPMC Eye Center is a eye care center located in Pittsburgh .Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Eye Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 7 clinical trials were completed, i.e. on average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Eye Center" #1 sponsor was "Glaukos Corporation" with 4 trials, followed by "Clearside Biomedical, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Vishal Jhanji" with 2 trials sponsored and "Allakos Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Eye Center" #1 collaborator was "Bionical Emas" with 1 trials as a collaborator, "Foundation Fighting Blindness" with 1 trials as a collaborator, "Pixium Vision LLC acts as sponosor in the US on behalf of Pixium Vision SA" with 1 trials as a collaborator, "Sun Pharmaceutical Industries Limited" with 1 trials as a collaborator and "Syne Qua Non Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Eye Center" are "Keratoconus" (3 trials), "Panuveitis" (2 trials), "Retinitis Pigmentosa" (2 trials), "Uveitis" (2 trials) and "Uveitis, Anterior" (2 trials). Many other conditions were trialed in "UPMC Eye Center" in a lesser frequency.

Most popular intervention types in "UPMC Eye Center" are "Drug" (16 trials), "Device" (7 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "KXL System" (2 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Eye Center" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Eye Center". 2 are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UPMC Eye Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Eye Center, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".